| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $16K | +0.0% |
| R&D Expense | $575K | +17.3% |
| SG&A Expense | $347K | -24.6% |
| Operating Income | -$2.6M | +23.6% |
| Pre-tax Income | -$2.7M | +29.6% |
| Net Income | -$2.7M | +29.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $58K | +117.9% |
| Total Assets | $276K | -4.4% |
| Current Liabilities | $3.6M | +19.9% |
| Total Liabilities | $3.7M | +19.4% |
| Stockholders' Equity | -$3.4M | -21.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.0M | +29.8% |
| Capital Expenditures | $58K | +0.0% |
| Investing Cash Flow | -$58K | +0.0% |
| Financing Cash Flow | $2.0M | -12.9% |
| Free Cash Flow | -$2.1M | +29.2% |